The primary outcome of this study is to evaluate desaturation episodes during the first 24 h post-bariatric surgery in patients having received an opioid or an opioid free anaesthesia. Desaturation is defined as a decrease of oxygen desaturation equal to or exceeding 4% of the baseline value. ODI (oxygen desaturation index), the total number of desaturation events divided by the total time of monitoring in hours, will be calculated to evaluate this outcome in both groups. In case of desaturation lasting longer than 10 seconds, oxygen (via nasal canula) will be administered as per post-anaesthesia care unit protocol. SP02 will be measured for 24 hours through non-invasive monitoring.
Opioid Free Anesthesia and Continuous Post-operative Pulse Oximetry Monitoring in the Obese Patient
Brief Summary
Anaesthesia has three major components, analgesia, muscle relaxation and hypnosis.
For a long time, opioids have been covering the analgesia function. (1) When using opioids, an analgesic effect is obtained per-operatively, however, not without side-effects. Post-operative complications such as: respiratory depression, post-operative nausea and vomiting, pruritus, acute opioid tolerance and hyperalgesia, difficulty voiding and ileus, are well known.
Opioid usage is an important risk factor of postoperative desaturation. Postoperative desaturation can lead to severe hypoxemia and even tissue hypoxia, followed by obvious cardiologic and neurological complications.
Thus, in patients at risk, such as the obese patient, experts suggest reducing opioid usage.
Non-opiate protocols implemented on the obese patient have been published. Non-opiate protocols have been established using a combination of ketamine, lidocaine and an alpha-2 agonist.
The main purpose of this pilot study is to evaluate whether patients undergoing an opioid free anaesthesia regime experience less desaturation episodes during the first 24 h post-bariatric surgery than patients having received an opioid anaesthesia regime.
Intervention / Treatment
-
Opioid free (COMBINATION_PRODUCT)Peroperative opioid free anesthesia will be obtained via a combination of dexmedetomidine, ketamine, lidocaine and magnesium sulfate
-
opioid group (COMBINATION_PRODUCT)Opioid anesthesia will follow the current standard approach of our hospital.
Condition or Disease
- Anesthesia
Phase
Study Design
| Study type: | INTERVENTIONAL |
|---|---|
| Status: | Completed |
| Study results: | No Results Available |
| Age: | 18 Years to 65 Years |
| Enrollment: | 30 (ACTUAL) |
| Funded by: | Other |
| Allocation: | Non-Randomized |
| Primary Purpose: | Diagnostic |
MaskingSINGLE:
|
|
Clinical Trial Dates
| Start date: | Apr 20, 2017 | ACTUAL |
|---|---|---|
| Primary Completion: | Jul 01, 2017 | ACTUAL |
| Completion Date: | Jul 01, 2017 | ACTUAL |
| Study First Posted: | Apr 24, 2017 | ACTUAL |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Jul 15, 2017 |
Sponsors / Collaborators
Lead Sponsor:
Université Libre de Bruxelles
Responsible Party:
N/A
Location
Anaesthesia has three major components, analgesia, muscle relaxation and hypnosis.
For a long time, opioids have been covering the analgesia function. When using opioids, an analgesic effect is obtained per-operatively, however, not without side-effects. Post-operative complications such as: respiratory depression, post-operative nausea and vomiting, pruritus, acute opioid tolerance and hyperalgesia, difficulty voiding and ileus, are well known. These complications may lead to a prolonged hospital stay.
Opioid usage is an important risk factor of postoperative desaturation. Postoperative desaturation can lead to severe hypoxemia and even tissue hypoxia, followed by obvious cardiologic and neurological complications.
Thus, in patients at risk, such as the obese patient, experts suggest reducing opioid usage.
Authors have indeed published non-opiate protocols implemented on the obese patient.
Non-opiate protocols have been established using a combination of ketamine, lidocaine and an alpha-2 agonist.
The main purpose of this pilot study is to evaluate whether patients undergoing an opioid free anaesthesia regime experience less desaturation episodes during the first 24 h post-bariatric surgery than patients having received an opioid anaesthesia regime.
For a long time, opioids have been covering the analgesia function. When using opioids, an analgesic effect is obtained per-operatively, however, not without side-effects. Post-operative complications such as: respiratory depression, post-operative nausea and vomiting, pruritus, acute opioid tolerance and hyperalgesia, difficulty voiding and ileus, are well known. These complications may lead to a prolonged hospital stay.
Opioid usage is an important risk factor of postoperative desaturation. Postoperative desaturation can lead to severe hypoxemia and even tissue hypoxia, followed by obvious cardiologic and neurological complications.
Thus, in patients at risk, such as the obese patient, experts suggest reducing opioid usage.
Authors have indeed published non-opiate protocols implemented on the obese patient.
Non-opiate protocols have been established using a combination of ketamine, lidocaine and an alpha-2 agonist.
The main purpose of this pilot study is to evaluate whether patients undergoing an opioid free anaesthesia regime experience less desaturation episodes during the first 24 h post-bariatric surgery than patients having received an opioid anaesthesia regime.
Participant Groups
-
Opioid free group using dexmedetomidine, ketamine, lidocaine, MgSO4
-
Opioid group using sufentanil, lidocaine, clonidine
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
| Maximum Age: | 65 |
| Age Groups: | Adult / Older Adult |
| Healthy Volunteers: | Yes |
Inclusion Criteria:
* All patients undergoing a gastric by-pass surgery will be screened.
* Patients with an ASA physical status of I-II-III (BMI \>30) will be included.
* Knowledge of either French, English or Dutch will be required in order to be enrolled in this study.
Exclusion Criteria:
* allergy or contraindications to one of the study drugs
* renal failure
* hepatic failure
* hyperthyroidism
* AV block 2 or 3
* severe bradycardia
* left ventricular failure
* unstable blood pressure
* severe respiratory disease
* epilepsy
* psychiatric disturbance.
* All patients undergoing a gastric by-pass surgery will be screened.
* Patients with an ASA physical status of I-II-III (BMI \>30) will be included.
* Knowledge of either French, English or Dutch will be required in order to be enrolled in this study.
Exclusion Criteria:
* allergy or contraindications to one of the study drugs
* renal failure
* hepatic failure
* hyperthyroidism
* AV block 2 or 3
* severe bradycardia
* left ventricular failure
* unstable blood pressure
* severe respiratory disease
* epilepsy
* psychiatric disturbance.
Primary Outcomes
More Details
| NCT Number: | NCT03124680 |
|---|---|
| Other IDs: | OFA |
| Study URL: | https://clinicaltrials.gov/study/NCT03124680 |
Last updated: Sep 29, 2023